Grief, Gabriela J., Deborah L. Sodickson, Bruce P. Bean, Eva J. Neer, and Ulrike Mende. Altered regulation of potassium and calcium channels by GABA B and adenosine receptors in hippocampal neurons from mice lacking G␣ o . J. Neurophysiol. 83: 1010Neurophysiol. 83: -1018Neurophysiol. 83: , 2000. To examine the role of G o in modulation of ion channels by neurotransmitter receptors, we characterized modulation of ionic currents in hippocampal CA3 neurons from mice lacking both isoforms of G␣ o . In CA3 neurons from G␣ o Ϫ/Ϫ mice, 2-chloro-adenosine and the GABA B -receptor agonist baclofen activated inwardly rectifying K ϩ currents and inhibited voltage-dependent Ca 2ϩ currents just as effectively as in G␣ o ϩ/ϩ littermates. However, the kinetics of transmitter action were dramatically altered in G␣ o Ϫ/Ϫ mice in that recovery on washout of agonist was much slower. For example, recovery from 2-chloro-adenosine inhibition of calcium current was more than fourfold slower in neurons from G␣ o Ϫ/Ϫ mice [time constant of 12.0 Ϯ 0.8 (SE) s] than in neurons from G␣ o ϩ/ϩ mice (time constant of 2.6 Ϯ 0.2 s). Recovery from baclofen effects was affected similarly. In neurons from control mice, effects of both baclofen and 2-chloroadenosine on Ca 2ϩ currents and K ϩ currents were abolished by brief exposure to external N-ethyl-maleimide (NEM). In neurons lacking G␣ o , some inhibition of Ca 2ϩ currents by baclofen remained after NEM treatment, whereas baclofen activation of K ϩ currents and both effects of 2-chloro-adenosine were abolished. These results show that modulation of Ca 2ϩ and K ϩ currents by G protein-coupled receptors in hippocampal neurons does not have an absolute requirement for G␣ o . However, modulation is changed in the absence of G␣ o in having much slower recovery kinetics. A likely possibility is that the very abundant G␣ o is normally used but, when absent, can readily be replaced by G proteins with different properties.
I N T R O D U C T I O N
Many effects of neurotransmitters are mediated by heterotrimeric G proteins, composed of G␣ and G␤␥ subunits. G o is the most abundant type of G protein in the brain (Huff et al. 1985; Neer et al. 1984; Sternweis and Robishaw 1984) . However, the range of effects mediated by G o is still unclear. Considering the abundance of the protein, the effects of inactivating the G␣ o gene in mice are surprisingly modest. Mice lacking G␣ o are viable and have no gross abnormalities of the brain, although they develop tremors and occasional seizures and have impaired motor control (Jiang et al. 1998; Valenzuela et al. 1997) .
One role of G proteins is to mediate neurotransmitter control of excitability by modulating the activity of ion channels (Hille 1994) . G protein activation of inwardly rectifying potassiumselective (GIRK) channels is one such pathway, mediated by direct binding of G␤␥ subunits to the channels (see Clapham and Neer 1997) . A second well-studied case of G proteinmediated modulation is transmitter inhibition of voltagedependent Ca 2ϩ channels, which can proceed by multiple pathways (Beech et al. 1992; Diverse-Pierluissi and Dunlap 1993; Diverse-Pierluissi et al. 1995; Dolphin 1995; Shapiro and Hille 1993) . One pathway prominent in many neurons is rapid, membrane-delimited inhibition mediated by direct binding of G␤␥ subunits to Ca 2ϩ channels (De Waard et al. 1997; Herlitze et al. 1996; Ikeda 1996; Zamponi et al. 1997) . Although G␤␥ subunits directly control GIRK channels and Ca 2ϩ channels, the type of the G␣ subunit from which the G␤␥ is released can determine specificity and kinetics of transmitter action. In addition, there is evidence for more direct involvement of G␣ subunits in at least some pathways (Furukawa et al. 1998a,b) .
Based on sensitivity to pertussis toxin (PTX), all transmitters known to activate GIRK channels appear to act through G␤␥ released from members of the G i /G o family, as do most, but not all, transmitters that inhibit Ca 2ϩ channels by rapid, membrane-delimited action (Dolphin 1995; Hille 1994; Wickman and Clapham 1995; Zhu and Ikeda 1994) . For Ca 2ϩ channel inhibition, G o has been specifically implicated by studies in a variety of neurons and neuroendocrine cells using antibodies or antisense oligonucleotides against specific G protein subunits (Campbell et al. 1993; Caulfield et al. 1994; Ewald et al. 1988; Hescheler et al. 1987; Kleuss et al. 1991; Lledo et al. 1992; McFadzean et al. 1989 McFadzean et al. , 1993 Menon-Johansson et al. 1993; Moises et al. 1994; Taussig et al. 1992) Mice lacking both isoforms of G␣ o present a useful model to study the role of G o in G protein-mediated ion channel modulation. Several alterations of channel modulation in G␣ o Ϫ/Ϫ mice are already known. In cardiac myocytes, acetylcholine activation of GIRK channels appears normal but there is disruption of a pathway by which muscarinic acetylcholine receptors regulate L-type Ca 2ϩ channels (Valenzuela et al. 1997) . In neurons, a recent study found that inhibition by opioid receptors of Ca 2ϩ channel in sensory neurons was diminished in G␣ o Ϫ/Ϫ mice (Jiang et al. 1998) .
To further study the role of G␣ o in control of neuronal GIRK channels and Ca 2ϩ channels, we examined transmitter modulation in hippocampal CA3 neurons where a number of trans-
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. mitters can both inhibit Ca 2ϩ channels and activate GIRK channels. We find that modulation of Ca 2ϩ channels and GIRK channels by GABA B and adenosine receptor agonists is unchanged in magnitude in neurons from G␣ o Ϫ/Ϫ mice but that kinetics of transmitter modulation are dramatically different compared with neurons from wild-type mice.
M E T H O D S

Cell preparation
, G␣ o ϩ/Ϫ , and G␣ o ϩ/ϩ mice were obtained from ϩ/Ϫ matings as described by Valenzuela et al. (1997) . Hippocampal CA3 pyramidal neurons were isolated enzymatically from the brains of mice (aged 9 -15 d). Mice were anesthetized with methoxyflurane before decapitation and hippocampi were dissected out in oxygenated ice-cold dissociation solution containing (in mM) 82 Na 2 SO 4 , 30 K 2 SO 4 , 5 MgCl 2 , 10 HEPES, 10 glucose, and 0.01% phenol red indicator (pH 7.4, adjusted with NaOH) and cut into 400 m thick slices. After incubation with 3 mg/ml protease XXIII in dissociation solution (37°C for 9 min), the enzyme solution was replaced with dissociation solution containing 1 mg/ml trypsin inhibitor and 1 mg/ml bovine serum albumin and the slices were stored at room temperature with oxygen blown over the surface of the fluid. As cells were needed, the CA3 region was dissected out of individual slices and triturated mechanically with fire-polished glass pipettes to liberate individual cells. Neurons were allowed to settle in the recording chamber for a few minutes and were superfused with Tyrode's solution containing (in mM) 150 NaCl, 4 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 glucose, and 10 HEPES (pH 7.4 with NaOH). CA3 pyramidal neurons were identified morphologically (Sodickson and Bean 1996) .
Electrophysiological methods
All recordings were done at room temperature using whole cell voltage clamp techniques (Hamill et al. 1981) . Patch pipettes were pulled from 100 l Boralex micropipettes (Dynalab, Rochester, NY). Pipette resistance ranged 2-6 M⍀ when pipettes were filled with internal solution. Pipette capacitance was reduced by wrapping the tip with thin strips of Parafilm. After the whole cell configuration was obtained in Tyrode's solution, the cell was lifted from the bottom of the chamber and control and agonist-containing external solutions were applied from different reservoirs through gravity-driven microcapillary perfusion pipes (internal diameter of 250 m), positioned directly in front of the cell. Solutions were exchanged (Ͻ1 s) by moving the pipes. Baclofen, 2-chloro-adenosine, and somatostatin were from RBI (Natick, MA) and N-ethyl-maleimide (NEM) was from Sigma. Agonists were stored as concentrated aliquots at Ϫ70°C and a fresh aliquot was diluted into external recording solution on the day of the experiment.
Data acquisition and analysis
Currents were recorded with an Axopatch 200 amplifier, filtered at 2 kHz, digitized at 20 -50 kHz, and stored on a computer using a Digidata interface and pClamp6 software (Axon Instruments, Foster City, CA). Series resistance (ϳ2-2.5 times higher than the pipette resistance) was compensated by 70 -90%. Membrane potentials were corrected for liquid junction potential.
Solutions and voltage protocol
We used ionic solutions and a voltage protocol that allowed simultaneous recording of Ca 2ϩ and inwardly rectifying K ϩ currents. The internal solution contained (in mM) 189 Cs 2 HPO 4 , 9 CsCl, 9 HEPES, 9 EGTA, 14 Tris-creatinePO 4 , 4 Mg-ATP, and 0.3 Tris-GTP (pH 7.4 with CsOH). Tris-creatinePO 4 , Mg-ATP, and Tris-GTP were added freshly each day to pipette solutions from aliquots stored at Ϫ70°C. ). To determine the time course of transmitter action, the voltage protocol was delivered every 2 s. Time-course plots show current measured at the end of the steps to Ϫ142 and Ϫ12 mV. Kinetics of K ϩ currents were analyzed only for cells in which there was a stable baseline before and after application of transmitters and where transmitter-activated current was Ն70 pA.
In some experiments, Ba 2ϩ currents through Ca 2ϩ channels were measured. These experiments used an external solution containing (in mM) 2 BaCl 2 , 160 NaCl, and 10 HEPES (pH 7.4 with NaOH), along with the standard Cs-based intracellular solution.
Data are expressed as mean Ϯ SE.
R E S U L T S
Simultaneous recording of baclofen effects on Ca 2ϩ and K
We wished to examine modulation of both voltage-dependent Ca 2ϩ currents and GIRK currents, both of which are modulated by a variety of transmitters in hippocampal CA3 neurons. Typically, these currents are examined in isolation using appropriate ionic substitutions (for example, blocking both inward and outward K ϩ currents when recording Ca 2ϩ channel currents). To facilitate efficient collection of data from the minimal necessary number of animals, we used ionic solutions and a voltage protocol that allowed simultaneous recording of Ca 2ϩ and K ϩ currents. The internal solution used Cs ϩ as the main cation, and the external solution was Tyrode's solution with increased (16 mM) KCl and containing 1 M tetrodotoxin (TTX) to block sodium currents.
With these solutions, transmitter-activated inwardly rectifying
can be recorded as a transmitter-sensitive inward current at voltages negative to Ϫ60 mV, because the internal Cs ϩ eliminates outward K ϩ currents but not inward K ϩ currents. Voltage-activated calcium current can be recorded in response to depolarizing voltage steps positive to Ϫ50 mV or so, and the calcium currents are well-isolated because outward K ϩ current that would otherwise overlap with them is eliminated by the internal Cs ϩ . Currents were thus recorded using a voltage protocol consisting of a strongly hyperpolarizing step (to Ϫ142 mV for 5 ms) and a depolarizing step to Ϫ12 mV (10 ms), which gave maximal Ca 2ϩ current. The currents elicited by this protocol, and the effects of baclofen on them, are shown in Fig. 1A in a recording from a neuron from a wild-type animal. The voltage steps were delivered from a steady holding potential of Ϫ92 mV. The hyperpolarizing step was given first because there was little time dependence of the current before or after this step, whereas the calcium current during the depolarizing step was followed by a slowly-decaying tail current (mainly from inward K ϩ current through voltage-activated K ϩ channels opened during the depolarization). The experiments shown in Fig. 1 , B and C, tested the ability of this protocol to separate the effects of baclofen on GIRK current and Ca 2ϩ current in a single application of transmitter. Resting current is inward at the holding potential of Ϫ92 mV, and the step to Ϫ142 mV elicits increased inward current with little time-dependence (the step is too short to activate I h , if present). Baclofen increases the inward current at both Ϫ92 mV and Ϫ142 mV, as expected for activation of GIRK channels. In the absence of baclofen, the step to Ϫ12 mV activates a time-dependent inward current that appears fully activated at the end of the 10-ms step, consistent with a voltage-activated Ca 2ϩ current. The inward current elicited by the depolarizing step is reduced by baclofen, as expected for calcium channel inhibition. In the experiment shown in Fig. 1B , the effect of baclofen was tested in the presence of 300 uM external barium, which blocks both inward and outward current through GABA B -activated potassium channels in rat neurons (Sodickson and Bean 1996) . With GIRK current blocked, baclofen had no effect on the currents at Ϫ92 mV and Ϫ142 mV but baclofen still effectively inhibited the depolarization-activated inward current. To test whether the current activated by depolarization to Ϫ12 mV was purely Ca 2ϩ current, we repeated the baclofen application in an external solution in which 2 mm Co 2ϩ replaced the 2 mM Ca 2ϩ present in normal external solution. In Co 2ϩ -containing solution, the current at Ϫ12 mV was near zero both in the absence and presence of baclofen. Thus in control conditions the current at Ϫ12 mV appears to be almost purely voltageactivated Ca 2ϩ current, and baclofen does not activate or influence any other current at this voltage.
The separation of baclofen effects on GIRK current and voltage-activated Ca 2ϩ current by the different voltage-sensitivity of the currents is illustrated in Fig. 2 , showing the current-voltage relationship (determined with 5-ms steps from Ϫ92 mV) in the absence and presence of baclofen. Baclofen induces inward current negative to Ϫ60 mV, and this baclofen-activated current is completely blocked by 300 uM external barium ( Fig. 2A) . Baclofen reduces inward current activated by steps positive to Ϫ50 mV, and both this current and the effect of baclofen are blocked by substitution of Co 2ϩ for Ca 2ϩ (Fig. 2B) . Voltageactivated Ca 2ϩ current is maximal at Ϫ12 mV, at which voltage the leak current remaining in 2 mM Co 2ϩ is near zero. Thus inward current at Ϫ12 mV in Ca 2ϩ -containing solution provides an accurate measurement of Ca 2ϩ current without requiring significant correction for leak current. In each cell studied, we first performed the voltage protocol with the 2 mM Co 2ϩ solution before testing transmitters in the 2 mM Ca 2ϩ solution, and the Ca 2ϩ current at Ϫ12 mV was corrected for any current (always small) remaining in Co 2ϩ -containing solution. The ability of 300 uM external barium to block the current activated by baclofen negative to Ϫ50 mV is consistent with this being an inwardly rectifying potassium current. To test further the identity of this current, we characterized its reversal FIG. 2. Current voltage relationships for baclofen (100 uM) application for various ionic conditions. Pulses (5 ms) were applied every 100 ms from a steady holding potential of Ϫ90 mV. Current at end of 5-ms pulse is plotted vs. membrane potential. (Different cell than in Fig. 1.) A: 300 M Ba 2ϩ blocks baclofen activation of inward current negative to Ϫ60 mV but has no effect on inhibition of inward current positive to Ϫ50 mV. B: substitution of Co 2ϩ for Ca 2ϩ blocks inward current elicited by depolarization positive to Ϫ50 mV. Net current is near zero at Ϫ12 mV and baclofen has no effect on current at this voltage. potential and current-voltage relationship in experiments using intracellular solution containing K ϩ in place of Cs ϩ ions (Fig.  3) . The current reversed at Ϫ62 mV, near the calculated equilibrium potential for potassium (Ϫ58 mV) and had an inwardly rectifying current-voltage relationship. It appeared identical in all respects to the baclofen-activated GIRK current previously characterized in rat hippocampal neurons using the same solutions (Sodickson and Bean 1996) .
Modulation of Ca 2ϩ and K ϩ currents in hippocampal CA3 neurons
We compared Ca 2ϩ and K ϩ current modulation by 2-chloroadenosine and the GABA B receptor agonist baclofen in freshly dissociated pyramidal CA3 neurons of hippocampi from G␣ o Ϫ/Ϫ mice and from G␣ o ϩ/ϩ littermates. The genotypes of the animals were confirmed after the experiment by PCR.
In CA3 neurons from G␣ o ϩ/ϩ mice, baclofen reliably activated inwardly rectifying K ϩ currents and inhibited Ca 2ϩ currents (Fig. 4A ). Both baseline currents and effects of baclofen were similar in cells from G␣ o Ϫ/Ϫ mice (Fig. 4B ). Baclofen inhibition of Ca 2ϩ current was identical in magnitude (25 Ϯ 1%; n ϭ 34) in cells from G␣ o Ϫ/Ϫ mice as in cells from G␣ o ϩ/ϩ mice (25 Ϯ 1%; n ϭ 30) (Fig. 4E ). Baclofen activation of inwardly rectifying K ϩ currents was also little different: baclofen-activated current (measured at Ϫ142 mV) was 6.6 Ϯ 0.5 pA/pF (n ϭ 34) in cells from G␣ o Ϫ/Ϫ mice compared with 7.9 Ϯ 0.7 pA/pF (n ϭ 30) in cells from G␣ o ϩ/ϩ mice (Fig. 4F ). The adenosine receptor agonist 2-chloro-adenosine also reliably activated inwardly rectifying K ϩ currents and inhibited Ca 2ϩ currents in CA3 neurons (Fig. 4C) . 2-Chloro-adenosine was just as effective in cells from G␣ o Ϫ/Ϫ mice as in those from G␣ o ϩ/ϩ mice (Fig. 4, D-F) . We also tested somatostatin ( control Ca 2ϩ currents and the voltage-dependence of inhibition by baclofen or 2-chloro-adenosine (which was most prominent for moderate depolarizations) were also not distinguishable between cells from G␣ o Ϫ/Ϫ and G␣ o ϩ/ϩ mice (data not shown).
Kinetics of K ϩ and Ca 2ϩ current modulation by G proteincoupled receptors
Although the magnitude of modulation was not different between neurons from G␣ o ϩ/ϩ and G␣ o Ϫ/Ϫ mice, the kinetics of the action of agonists were different, especially the time course of recovery. Figure 5 shows the time course of action of baclofen on K ϩ and Ca 2ϩ currents in G␣ o Ϫ/Ϫ and G␣ o ϩ/ϩ mice, from recordings like those in Fig. 2 . In cells from G␣ o ϩ/ϩ mice, K ϩ current was activated rapidly on exposure to agonist and it also deactivated rapidly on return to agonist-free solution. Both activation and deactivation of K ϩ current by baclofen were too fast to be clearly resolved with the 2-s sampling period of the experiments (Fig. 5A) . Interestingly, the kinetics of agonist action on Ca 2ϩ current were somewhat different from agonist activation of K ϩ current in cells from G␣ o ϩ/ϩ mice, even when determined simultaneously during the same application of agonist. Both onset of inhibition of Ca 2ϩ current and recovery from inhibition were biphasic, with a predominant, rapid (Յ2 s) phase followed by a smaller, slower phase.
In comparing cells from G␣ o ϩ/ϩ mice and G␣ o Ϫ/Ϫ mice, we focused on recovery kinetics, which were dramatically different. In G␣ o ϩ/ϩ mice, recovery from Ca 2ϩ current inhibition by baclofen consisted of an initial fast phase with a time constant Յ2 s, where 70 -90% of effect recovered, and a remaining small component with a time constant of ϳ5-20 s. The fast phase was poorly resolved with the 2 s sampling interval, but the magnitude (22 Ϯ 4%) and time constant (7.0 Ϯ 0.7 s, n ϭ 15) of the slower phase could be resolved reasonably well. In cells from G␣ o Ϫ/Ϫ mice, recovery from agonist was much slower than in G␣ o ϩ/ϩ mice (Fig. 5B) . In G␣ o Ϫ/Ϫ mice, recovery from activation of K ϩ current by baclofen was slow enough to be resolved and could be fit well by a single exponential, with an average time constant of 7.1 Ϯ 1.0 s (n ϭ 12). This is at least fourto fivefold slower than the recovery from activation of K ϩ current in cells from normal mice (complete in Ͻ2 s). Recovery from baclofen effects on Ca 2ϩ current was also slower in cells from G␣ o Ϫ/Ϫ mice. In G␣ o Ϫ/Ϫ mice, the time course of recovery from Ca 2ϩ current inhibition was sigmoidal, with a delay in recovery when the cell was removed from baclofen. This was followed by a main phase of recovery that was fit well with a single exponential. This had an average time constant of 14.5 Ϯ 1.1 s (n ϭ 23). It was notable that recovery from the effects of baclofen on Ca 2ϩ current was slower than decay of K ϩ current, even when monitored simultaneously in the same cell (Fig. 5B) .
The length of agonist exposure had no obvious effect on recovery kinetics. If cells were continuously exposed for 1 min to 50 M baclofen, Ca 2ϩ currents recovered from inhibition with a similar time constant as for short exposure in the same cell (for cells from both G␣ o ϩ/ϩ and G␣ o Ϫ/Ϫ mice; data not shown). Recovery from exposure to 2-chloro-adenosine was also slower in cells from G␣ o Ϫ/Ϫ mice. 6A) and G␣ o Ϫ/Ϫ (Fig. 6B) mice. In cells from G␣ o ϩ/ϩ mice, recovery from 2-chloro-adenosine was rapid. Effects of 2-chloroadenosine on K ϩ current recovered too fast to be resolved with the 2-s sampling interval, as for baclofen effects in wild-type cells. 2-Chloro-adenosine effects on Ca 2ϩ currents in wild-type cells recovered more slowly than the effects on K ϩ currents but (unlike those of baclofen) could generally be fit well by a single exponential (Fig. 6A) . The average time constant was 2.6 Ϯ 0.2 s (n ϭ 12). In cells from G␣ o Ϫ/Ϫ mice, recovery from 2-chloro-adenosine effects was much slower than in G␣ o ϩ/ϩ mice (Fig. 6B) . Recovery from activation of K ϩ current by 2-chloro-adenosine in G␣ o Ϫ/Ϫ mice could be fit well by a single exponential, with an average time constant of 7.9 Ϯ 0.9 s (n ϭ 12). Recovery from 2-chloroadenosine effects on Ca 2ϩ current was sigmoidal, with an initial delay followed by a main phase of recovery that was fit well with a single exponential (Fig. 6B ). The main phase had an average time constant of 12.0 Ϯ 0.8 s (n ϭ 16). As for the effects of baclofen on cells from G␣ o Ϫ/Ϫ mice, recovery from effects on Ca 2ϩ current was slower than decay of agonist-activated K ϩ current when monitored in the same cell (Fig. 6B) .
The much slower recovery rates from agonist effects in cells from G␣ o Ϫ/Ϫ animals compared with G␣ o ϩ/ϩ littermates were also seen in less systematic experiments with somatostatin and 1R-2S-ACPD (not shown). Slowed recovery was similarly seen in experiments in which 2 mM Ba 2ϩ rather than 2 mM Ca 2ϩ was the current carrier for calcium channel current (not shown).
NEM-sensitivity of K ϩ and Ca 2ϩ current modulation in G␣ o
Ϫ/Ϫ and G␣ o ϩ/ϩ mice The sulfhydryl alkylating agent N-ethyl-maleimide (NEM) disrupts some but not other G protein-mediated transmitter pathways when applied briefly to the outside of the cell. Among the different pathways of Ca 2ϩ current inhibition in sympathetic neurons, NEM effects appear to be selective for pathways that are also sensitive to pertussis toxin (Jeong and Ikeda 1998; Shapiro et al. 1994; Wollmuth et al. 1995) . We attempted to study the pertussis toxin sensitivity of transmitter effects in CA3 neurons, but the cells deteriorated during overnight exposure to pertussis toxin. Thus short-term NEM exposure, which can be performed quickly on freshly dissociated cells, was a useful tool for distinguishing various pathways. In rat CA3 neurons, brief (1 min) exposure to 50 uM NEM completely blocks activation of inwardly rectifying K ϩ current by baclofen (Sodickson and Bean 1996) , suggesting that this response is mediated by G i or G o . Figure 7A shows the effect of NEM exposure on baclofen effects in a CA3 neuron from a G␣ o ϩ/ϩ mouse. Both baclofen activation of K ϩ current and inhibition of Ca 2ϩ current were completely disrupted by NEM, which had no effect on basal currents. However, in neurons from G␣ o Ϫ/Ϫ mice, NEM had a Currents were elicited by voltage protocol as in Fig. 1 except that step to Ϫ142 mV was for 10 ms and step to Ϫ12 mV was for 20 ms. Thin trace: control. Bold trace: 50 M baclofen (traces overlap after NEM). Bottom: time course of baclofen effects. Gray bars: exposure to baclofen. Interrupted x-axis indicates exposure of neuron to NEM for 1 min between measurements of baclofen responses. NEM had no effect on the basal currents. B: CA3 neuron from G␣ o Ϫ/Ϫ mouse studied with the same experimental protocol. differential effect on K ϩ and Ca 2ϩ current modulation by baclofen (Fig. 7B) . Whereas baclofen activation of K ϩ current was abolished, as in cells from G␣ o ϩ/ϩ mice, NEM reduced but did not abolish the baclofen effect on Ca 2ϩ current. We also examined the effect of NEM on modulation by 2-chloro-adenosine in both G␣ o Ϫ/Ϫ mice and G␣ o ϩ/ϩ mice. Figure 8 shows the responses to 2-chloro-adenosine of the same neurons tested with baclofen in Fig. 7 . In the G␣ o ϩ/ϩ cell, NEM blocked both effects of 2-chloro-adenosine (Fig. 8A) . NEM also completely blocked both effects of 2-chloro-adenosine in the G␣ o Ϫ/Ϫ cell (Fig. 8B) . Thus in the same cell, NEM blocked the effect of baclofen on Ca 2ϩ currents only partially and completely blocked the effect of 2-chloro-adenosine. The results of the cells shown in Figs. 7 and 8 were typical of the collected results on many cells, summarized in Fig. 9 .
D I S C U S S I O N
Interpretation of slowed kinetics
The simplest interpretation for the dramatically different kinetics of transmitter action in mice lacking G o is that in wild-type mice, G o is the predominant G protein used for coupling both GABA B and adenosine receptors to both K ϩ and Ca 2ϩ channels and that in G␣ o Ϫ/Ϫ mice, different G proteins take over this role, acting with equal efficacy but different kinetics. Isoforms of G␣ i are the most likely candidates for mediating modulation by GABA B and adenosine receptors in hippocampal neurons from G␣ o Ϫ/Ϫ mice. The complete elimination by brief exposure to NEM of the effects of adenosine on both Ca 2ϩ and K ϩ current and the effects of baclofen on K ϩ current are consistent with these being mediated by G␣ i in G␣ o Ϫ/Ϫ mice. The effects of baclofen on Ca 2ϩ current were only partially blocked by NEM treatment in G␣ o Ϫ/Ϫ mice, suggesting an additional contribution by a G protein other than G␣ i .
GTPase activity and recovery
It appears that G␣ o is necessary for normal rapid kinetics seen in current modulation by G protein-coupled receptors in hippocampal CA3 neurons. What determines the rate of recovery from transmitter effects is not known. The rate-limiting step could be GTP hydrolysis by the G␣ subunit (see Breitwieser and Szabo 1988; Zhou et al. 1997) . If G␣ o does play a predominant role in coupling GABA B and adenosine receptors to Ca 2ϩ and K ϩ channels in wild-type mice and is substituted mainly by G␣ i in G␣ o Ϫ/Ϫ mice, it is not obvious why the kinetics are slower, because the intrinsic rates of GTPase activity of G␣ i1 , G␣ i2 , and G␣ i3 are all similar to that of G␣ o (Linder et al. 1990 ). However, the intrinsic GTPase rate for purified G␣ o subunits is only about 2 min Ϫ1 (Kurachi 1995; Linder et al. 1990) , an order of magnitude slower than the recovery from effects of transmitters on either GIRK channels or Ca 2ϩ channels (0.5-2 s
Ϫ1
). Recently, a family of regulators of G protein signaling (RGS) proteins have been discovered which influence G protein signaling by speeding up GTPase activity of various G␣ subunits (Watson et al. 1996; Zerangue and Jan 1998) . RGS proteins appear to be widely distributed in the brain (Gold et al. 1997) , and have been shown to speed kinetics of K ϩ and Ca 2ϩ channel modulation in heterologous expression systems (Doupnik et al. 1997; Jeong and Ikeda 1998; Melliti et al. 1999; Saitoh et al. 1997) . A candidate RGS protein for the responses we studied is RGS8, which is expressed in neural tissue (Gold et al. 1997 ) and binds to both G␣ o and G␣ i3 subunits (Saitoh et al. 1997) . One possibility is that the relevant RGS proteins in CA3 neurons are less efficacious on G i isoforms that substitute for G o in the G␣ o Ϫ/Ϫ mice.
Kinetics of recovery of I K versus I Ca
In G␣ o Ϫ/Ϫ mice, kinetics of recovery from agonist effects on both GIRK current and Ca 2ϩ current were slow enough to be well-resolved. It was striking that, when monitored simultaneously in the same cell, recovery of effects on Ca 2ϩ current were slower (by a factor of 2-4) than recovery of GIRK current. Both effects are believed to be mediated by direct binding of ␤␥ subunits to the channels. Why then do the kinetics differ? One possibility is that the difference in recovery kinetics reflects different stoichiometry of ␤␥ binding to GIRK channels and calcium channels. Activation of GIRK channels appears to require binding of multiple ␤␥ subunits (Ito et al. 1992; Krapivinsky et al. 1995) , whereas binding of a single ␤␥ subunit might be enough to inhibit a calcium channel (Zamponi and Snutch 1998) . If so, activation of GIRK channels would be expected to have a steeper dependence on the concentration of free ␤␥ subunits. As the concentration of free ␤␥ subunits declines after removal of agonist, significant inhibition of calcium channels might remain after the concentration is too low for activation of GIRK channels.
Specificity and plasticity of G proteins
Overall, our results in hippocampal CA3 neurons are consistent with previous evidence from other neurons and cell lines suggesting that effects of many neurotransmitters on Ca 2ϩ channels are mediated by G o . However, the results also show that other G proteins are capable of mediating inhibition with equal efficacy. This implies that there is no special need for G o in the coupling pathways. It may be that G o predominates in normal mice not because of any intrinsic selectivity for G o in the pathways but simply as a result of a large excess of G o compared with other G proteins. Perhaps the most surprising result from our experiments is the lack of change in the magnitude of modulation of Ca 2ϩ channels and GIRK channels, despite the likelihood that G o normally mediates modulation. An obvious possibility is that with loss of G o there is compensatory up-regulation of expression of other G proteins. However, at least at the level of the whole brain, there is little or no change in expression of ␣ subunits of other G proteins in G␣ o Ϫ/Ϫ mice (Mende et al. 1998) , and there is a dramatic reduction of G␤␥ (to ϳ30% of wild-type). Another possibility is that even though the total level of G i /G o family proteins decreases, the local concentration of G proteins near the effector channels may not change. Perhaps the concentration of G proteins used for signaling to ion channels is tightly regulated in small subcellular areas comprising clusters of receptors, G proteins, and ion channels (and probably RGS proteins). Comparing the speed of modulation with two-dimensional diffusion, it can be calculated that receptors, G proteins, and channels are within at least 1 u of one another (Hille 1992; Zhou et al. 1997) , suggesting the existence of mechanisms by which location and stoichiometry of these proteins are coordinated. In fact, the elements of the G-protein-coupled cascade mediating phototransduction in Drosophila are known to be colocalized by means of a protein with five PDZ domains (Tsunoda et al. 1997) . If an analogous mechanism exists for regulation of Ca 2ϩ channels and K ϩ channels by G protein-coupled receptors, the level of expression of G proteins is probably not the limiting factor in formation of such complexes, because most G proteins are present in large excess over receptors or effectors. Thus it may be reasonable that a large reduction in total G protein expression could result in little change in local concentration near receptors and channels. Interestingly, adenylate cyclase activity is also unchanged by the dramatic reduction in G␤␥ in G␣ o Ϫ/Ϫ mice, also suggesting compartmentalization or the existence of local membrane pools (Mende et al. 1998) .
Consequences for brain function
The slowed kinetics of recovery from agonist effects in G␣ o Ϫ/Ϫ mice could contribute to changes in neurological function. It seems likely that GABA B -mediated inhibitory synaptic currents might also decay more slowly in G␣ o Ϫ/Ϫ mice, because synaptic currents measured in brain slices (Otis et al. 1993 ) have similar kinetics as GIRK currents in isolated cells (Sodickson and Bean 1996) . GABA B receptors can also act presynaptically to inhibit transmission (e.g., Dittman and Regehr 1997; Thompson and Gähwiler 1992) , with kinetics very similar to that of inhibition of Ca 2ϩ channels (Dittman and Regehr 1997; Pfrieger et al. 1994) . Thus presynaptic effects of GABA are also likely prolonged in G␣ o Ϫ/Ϫ mice. Prolonging GABA B effects at both presynaptic and postsynaptic sites may change the dynamic control of synaptic strength at many synapses and contribute to the neurological changes seen in G␣ o Ϫ/Ϫ mice. Other changes, including subtle changes in development, are also possible. This work was supported by National Institutes of Health Grants HL-35034 to B. P. Bean and HL-52320 and GM-36359 to E. J. Neer.
